Literature DB >> 2998658

Detection and preliminary characterization of a transmissible agent inducing autoantibody against Golgi-antigen.

E Weiland, F Weiland.   

Abstract

A transmissible agent inducing autoantibody has been found in association with tumours induced in STU mice with the progressor strain of Moloney sarcoma virus (Mo-MSV). The activity of the agent detectable in serum from tumour-bearing hosts was expressed by development of autoantibody against Golgi-associated evolutionary conserved antigen (Weiland et al. 1984). This agent was tentatively designated 'AGIA', anti-Golgi inducing agent, on account of its most remarkable biological activity. Concomittant with autoantibodies were cytotoxic antibodies reactive with a Mo-MSV non-producer transformant (Sac). Both antibody activities were regularly detectable 2 weeks after inoculation of the agent. At that time the antibody containing serum possessed an infectivity titre of approximately 10(7.5) ID50/ml. Signs of illness were not observed during this period. The antibody-inducing agent was lost from progressor Mo-MSV transformants during their first passage in culture. Neither murine embryo fibroblasts nor murine tumour cells were permissive for propagation of the agent in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998658      PMCID: PMC1577393     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  A plaque assay for murine leukemia virus using enzyme-coupled antibodies.

Authors:  B A Nexo
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

2.  A quantitative study on transformation of hamster embryo cells in vitro by murine sarcoma viruses (Harvey and Moloney).

Authors:  R C Ting; A V Bader
Journal:  Virology       Date:  1969-10       Impact factor: 3.616

3.  Transformed cell lines derived from progressor Sarcoma virus (Moloney) induced tumors. I. Differences in pathogenicity between C type viruses from producer and helper virus infected nonproducer cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

4.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

5.  Detection of cytotoxic lymphoid spleen cells from STU-mice with Moloney sarcoma by a 3H-proline microcytotoxicity assay.

Authors:  E Weiland; M Mussgay
Journal:  Med Microbiol Immunol       Date:  1976-06-01       Impact factor: 3.402

6.  Antibodies from patients with autoimmune disease react with a cytoplasmic antigen in the Golgi apparatus.

Authors:  M J Fritzler; J Etherington; C Sokoluk; T D Kinsella; D W Valencia
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

7.  Autoantibody activity against evolutionary conserved juxtanuclearly arranged antigen in mice with tumors induced by a progressor Moloney sarcoma virus transformant.

Authors:  E Weiland; F Weiland; H J Thiel
Journal:  Exp Cell Biol       Date:  1984

8.  Tumors induced by progressor sarcoma virus (Moloney) in mice: growth in the presence of an immune response and isolation of autonomously growing cells.

Authors:  E Weiland; M Mussgay
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

9.  Anti-golgi complex autoantibodies in a patient with Sjögren syndrome and lymphoma.

Authors:  J L Rodríguez; C Gelpi; T M Thomson; F J Real; J Fernández
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

10.  Nonproducer malignant tumor cells with rescuable sarcoma virus genome isolated from a recurrent Moloney sarcoma.

Authors:  E Weiland; M Mussgay; F Weiland
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.